Md Nayab Sulaimani is currently working as a PhD candidate at the Centre for Interdisciplinary Research in Basic Sciences (CIRBSc), Jamia Millia Islamia (JMI), New Delhi, India. He is pursuing a doctoral degree in Computational Biology, with his research centered on the computational investigation of mitogen-activated protein kinases (MAPKs) and their role across various cancer types. His work aims to contribute to the field of precision oncology by identifying key MAPK targets involved in tumorigenesis and facilitating the development of targeted therapeutic interventions.

His research integrates high-throughput transcriptomic analysis, molecular docking, molecular dynamics (MD) simulations, structure-based drug design, and cheminformatics, forming a comprehensive in-silico approach for understanding molecular mechanisms and advancing drug discovery. His doctoral project, titled "Exploring the Role of Mitogen-Activated Protein Kinases in Tumorigenesis for Precision Diagnosis and Targeted Therapy," seeks to identify and characterize potential MAPK biomarkers and druggable sites that could drive personalized cancer treatment strategies.

Md Nayab Sulaimani holds an M.Sc. in Biophysics and a B.Sc. in Biosciences, and he is ARS-NET and GATE qualified, reflecting his strong academic foundation in life sciences and computational research. His research contributions include transcriptomic data analysis in pan-cancer studies, computer-aided drug discovery, molecular docking, molecular dynamics simulations, and essential dynamics analysis, with a focus on improving the accuracy and efficiency of therapeutic development.